Cancer

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus

VANCOUVER, BC / ACCESS Newswire / February 4, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces…

6 days ago

This World Cancer Day, St. Baldrick’s Foundation Leads the Charge Against Childhood Cancer

Los Angeles, California--(Newsfile Corp. - February 4, 2026) - This World Cancer Day, the St. Baldrick's Foundation, the largest charity…

6 days ago

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools…

6 days ago

Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors

NEWTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection,…

6 days ago

beHuman Raises $4 Million Seed Round to Expand Equitable, AI-Driven Early Cancer Detection Nationwide

Led by Santé Ventures, the funding will enable beHuman to expand its network of health insurance partners and end customers…

6 days ago

Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 4, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)…

7 days ago

Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform

Montreal, Quebec--(Newsfile Corp. - February 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"),…

7 days ago

Health Union Expands Industry-Leading Portfolio with Launch of New Online Communities in Oncology and Rare Diseases

New digital health communities for Cancer, Idiopathic Hypersomnia, and Primary Biliary Cholangitis (PBC) underscore Health Union's gold-standard approach to patient…

1 week ago

Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA…

1 week ago

MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study

Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer Research (AACR)Annual…

1 week ago